<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="20108">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02845128</url>
  </required_header>
  <id_info>
    <org_study_id>PR(AG)206/2016</org_study_id>
    <nct_id>NCT02845128</nct_id>
  </id_info>
  <brief_title>Prospective Validation of the ROX Index</brief_title>
  <official_title>Prospective Validation of the ROX Index Utility in Predicting Failure of HFNC Treatment in Patients With Acute Respiratory Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari Vall d'Hebron Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitari Vall d'Hebron Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multicentric cohort study recruiting patients admitted to the intensive care unit (ICU) with
      acute respiratory failure (ARF) and receiving treatment with high-flow nasal cannula (HFNC).

      This is a second part of the initial study PF(AG)101/2011 where the investigators created
      the ROX index to predict the need of failure with HFNC treatment in patients with ARF
      secondary to pneumonia, and the investigators want to validate ROX index with this second
      prospective cohort results.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a second part of the initial study PF(AG)101/2011 where the investigators created
      the ROX index to predict the need of failure with HFNC treatment in patients with ARF
      secondary to pneumonia, and the investigators want to validate ROX index with this second
      prospective cohort results.

      The investigators are now recruiting a second cohort of patients prospectively in order to
      analyse results and validate ROX index.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>predicting failure of HFNC treatment using ROX index</measure>
    <time_frame>5 days after HFNC onset</time_frame>
    <description>5 days after high-flow nasal cannula onset</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Validation</condition>
  <arm_group>
    <arm_group_label>HFNC failure</arm_group_label>
    <description>requiring intubation and invasive mechanical ventilation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HFNC success</arm_group_label>
    <description>not requiring intubation nor invasive mechanical ventilation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>predicting failure of HFNC treatment using ROX index</intervention_name>
    <description>Using ROX index to predict the need for mechanical ventilation in patients admitted to ICU with ARF receiving treatment with high-flow nasal cannula</description>
    <arm_group_label>HFNC failure</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients admitted in the ICU under ARF situation receiving treatment with HFNC
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients admitted in the ICU under ARF situation receiving treatment with HFNC

        Exclusion Criteria:

          -  under 18 years old

          -  intubated and mechanically ventilated previously of 24h before HFNC treatment started

          -  limitation of therapeutic effort

          -  immediate intubation after ICU arrival
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oriol Roca, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Vall d'Hebron University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Berta Caralt, specialist</last_name>
    <phone>932746209</phone>
    <email>bcaralt@vhebron.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Oriol Roca, Doctor</last_name>
    <phone>932746209</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona</name>
      <address>
        <city>Bacelona</city>
        <state>Barcelona</state>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Berta Caralt, specialist</last_name>
      <phone>932746209</phone>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <lastchanged_date>July 26, 2016</lastchanged_date>
  <firstreceived_date>July 5, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
